Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
19.7M
-
Shares change
-
+2.5M
-
Total reported value, excl. options
-
$1.31B
-
Value change
-
+$168M
-
Put/Call ratio
-
0.03
-
Number of buys
-
114
-
Number of sells
-
-69
-
Price
-
$66.87
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q3 2023
226 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q3 2023.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.7M shares
of 835M outstanding shares and own 2.35% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.48M shares), GOLDMAN SACHS GROUP INC (1.98M shares), RENAISSANCE TECHNOLOGIES LLC (1.84M shares), Robeco Institutional Asset Management B.V. (1.67M shares), VANGUARD GROUP INC (1.05M shares), DIMENSIONAL FUND ADVISORS LP (827K shares), Man Group plc (752K shares), GQG Partners LLC (722K shares), STATE STREET CORP (719K shares), and BANK OF AMERICA CORP /DE/ (571K shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.